| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21d03c7c814b4a81ce7bdb05b212d857 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0066 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861 |
| filingDate |
2020-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ad02319b901cd3347b36c083fdce5e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9883d7c8d2a7469a0f5dc3b2d4d2e248
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5b19f23e5318c329174771e321ff037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdb7ca1af2b70ac73ae9681222b3aab7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d767fa105e3c0b8137e0ba768c7c500
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c7988b46617af4bd6fcfa7bfe32bf96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81e6b458b1be155f9c43a006aae8da66 |
| publicationDate |
2020-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020223296-A1 |
| titleOfInvention |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord |
| abstract |
The present disclosure relates to AAVs encoding a SOD1 targeting polynucleotide which may be used to treat amyotrophic lateral sclerosis (ALS) and delivery methods for the treatment of spinal cord related disorders including ALS. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11542506-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11434502-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11603542-B2 |
| priorityDate |
2019-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |